This article is more than 5 years old. Information may no longer be current.

Alma Lasers gains FDA approval for skin resurfacing module

ATLANTA — Alma Lasers has received FDA clearance for its new fractionated skin resurfacing module, the company announced this week.

The Pixel RF uses “InMotion Refractive Radiofrequency Micro Plasma Technology,” which ablates and heats the skin through controlled, focused delivery of energy without using disposables, according to a company news release.

The technology causes evaporation, mechanical damage and thermal damage below the epidermis, which provides significant dermal impact, but minimal epidermal disruption, and can be used on all skin types, the company said. The fractionated resurfacing with RF technology does not harm the skin’s outer layer, resulting in healing time that is faster than traditional CO₂ lasers, according to the release. Alma Lasers said monthly treatments typically deliver optimal results in 2 to 3 months.

“The Pixel RF module adds new versatility to the Accent [product line],” Avi Farbstein, executive vice president and general manager of Alma Lasers, said. “Practitioners now have the multiple technologies they need for an overall best-in-class treatment depending on each individual client’s age, skin condition and downtime preference.” — by Joan-Marie Stiglich